<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for endovascular aortic repair</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for endovascular aortic repair</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for endovascular aortic repair</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">E. Andrew Ochroch, MD, MSCE</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter D Slinger, MD, FRCPC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1881360187"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endovascular aortic repair (EVAR) has become a standard approach to treatment for thoracic and abdominal aortic aneurysms, accounting for well over one-half the patients who would otherwise undergo an open surgical repair. Since EVAR does not require intrathoracic or intraabdominal exposure of the aorta, or aortic cross-clamping, perioperative morbidity and mortality are reduced compared with open repair. Also, EVAR has made treatment possible for some patients with comorbidities who might not otherwise be candidates for aortic repair.</p><p>Vascular access for EVAR is achieved via access to the femoral or iliac vessels, either percutaneously or via small incisions; thus, the procedure may be accomplished with the aid of local/regional anesthetic techniques with monitored anesthesia care (MAC), neuraxial anesthesia, or general anesthesia.</p><p>This topic will review the preoperative anesthesia consultation and each of these anesthetic options for thoracic or abdominal EVAR. Separate topics review anesthetic management for open repair of the abdominal aorta or the descending thoracic aorta. (See  <a class="medical medical_review" href="/d/html/94260.html" rel="external">"Anesthesia for open abdominal aortic surgery"</a> and  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery"</a>.)</p><p class="headingAnchor" id="H1177162579"><span class="h1">SURGICAL TECHNIQUES</span><span class="headingEndMark"> — </span>Significant advances in imaging technology allows for accurate three-dimensional reproduction of any aortic aneurysm, which provides optimal preprocedural planning and stent choice and stent production commissioned to a particular specification even with complex anatomy [<a href="#rid1">1</a>]. Such advances together with increased clinical experience have reduced the need for different approaches to descending thoracic aneurysms versus abdominal aneurysms. Further details are available in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16919.html" rel="external">"Endovascular devices for abdominal aortic repair"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8191.html" rel="external">"Endovascular repair of the thoracic aorta"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16973.html" rel="external">"Endovascular devices for thoracic aortic repair"</a>.)</p><p></p><p class="headingAnchor" id="H283866358"><span class="h1">PREANESTHETIC ASSESSMENT</span><span class="headingEndMark"> — </span>Most patients with thoracic and/or abdominal aortic aneurysm are older and have major cardiovascular and other comorbidities (eg, coronary artery disease, hypertension, obesity, diabetes, hyperlipidemia, smoking, and chronic obstructive pulmonary disease) [<a href="#rid2">2</a>]. Many have had recent intravenous (IV) contrast for angiography, with consequent risk of contrast-induced nephropathy (CIN). Although EVAR is associated with lower perioperative morbidity and mortality compared with open surgical repair, risk for conversion to open intraabdominal or intrathoracic repair is present [<a href="#rid3">3,4</a>]. Thus, preoperative evaluation is as thorough for EVAR as for open repair [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/94260.html" rel="external">"Anesthesia for open abdominal aortic surgery", section on 'Preanesthetic consultation'</a> and  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery", section on 'Preanesthetic assessment'</a>.)</p><p>Risks that affect anesthetic management will be briefly summarized here, while further details are available in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm", section on 'Preoperative risk assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8191.html" rel="external">"Endovascular repair of the thoracic aorta", section on 'Medical risk assessment'</a>.)</p><p></p><p></p><p>Particular emphasis is placed on the cardiovascular and renal systems:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular assessment</strong> – We obtain a preoperative electrocardiogram (ECG), as recommended by professional societies, as a useful baseline if the postoperative ECG is abnormal [<a href="#rid5">5-8</a>]. We obtain additional cardiac testing selectively in patients with changes in cardiac symptoms and functional status. (See  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery", section on 'Initial evaluation'</a> and  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery", section on 'Testing to further define risk'</a>.)</p><p></p><p class="bulletIndent1">Either abdominal or thoracic EVAR are procedures associated with intermediate risk for a perioperative cardiovascular event (at least 1 percent) [<a href="#rid3">3,5</a>]. Notably, patients with known preexisting right ventricular dysfunction have a higher risk for major postoperative cardiac complications including cardiovascular mortality, nonfatal cardiac arrest, myocardial infarction, development of congestive heart failure, and stroke after major vascular surgery, including endovascular aortic surgery [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal assessment</strong> – We obtain a creatinine level in the immediate preoperative period to compare with previous measurements to determine if the intravascular contrast dye used in preoperative imaging decreased creatinine clearance. Then we allow sufficient time between the last contrast dye load and the time of the currently planned procedure when possible (typically two weeks), and we obtain consultation with a nephrologist. (See  <a class="medical medical_review" href="/d/html/7221.html" rel="external">"Prevention of contrast-associated acute kidney injury related to angiography"</a>.)</p><p></p><p class="bulletIndent1">Severe renal dysfunction after elective abdominal or thoracic EVAR occurs in 0.7 to 2 percent of patients. This is primarily due to the administration of IV contrast agents, but also influenced by dislodgement of embolic debris by manipulation of intravascular catheters and wires near the renal arteries, or impingement of the renal ostia by the graft. Patients undergoing emergency endovascular therapy for a ruptured aneurysm have a higher incidence of renal as well as other complications. (See  <a class="medical medical_review" href="/d/html/16918.html" rel="external">"Complications of endovascular abdominal aortic repair", section on 'Contrast-induced nephropathy'</a> and  <a class="medical medical_review" href="/d/html/16918.html" rel="external">"Complications of endovascular abdominal aortic repair", section on 'Renal ischemia'</a> and  <a class="medical medical_review" href="/d/html/8191.html" rel="external">"Endovascular repair of the thoracic aorta"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medication management</strong> – We continue chronically administered beta-blockers, statins, and antihypertensives in the perioperative period, similar to other noncardiac surgical cases with high cardiovascular risk. (See  <a class="medical medical_review" href="/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery", section on 'Beta blockers'</a> and  <a class="medical medical_review" href="/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery", section on 'Statins'</a> and  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management", section on 'Cardiovascular medications'</a>.)</p><p></p><p class="headingAnchor" id="H1123114438"><span class="h1">INTRAOPERATIVE MONITORING</span><span class="headingEndMark"> — </span>In addition to standard noninvasive monitoring, including electrocardiography (ECG) with leads II and V<sub>5</sub>, with computerized ST-segment trending to detect myocardial ischemia and/or arrhythmias, pulse oximetry (SpO<sub>2</sub>), and intermittent noninvasive blood pressure (BP) cuff measurements  (<a class="graphic graphic_table graphicRef110080" href="/d/graphic/110080.html" rel="external">table 1</a>), cardiovascular monitoring and neuromonitoring may be employed. We use continuous ECG monitoring. (See  <a class="medical medical_review" href="/d/html/100067.html" rel="external">"Basic patient monitoring during anesthesia"</a> and  <a class="medical medical_review" href="/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Monitoring for myocardial ischemia'</a>.)</p><p class="headingAnchor" id="H750773909"><span class="h2">Cardiovascular monitoring</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial blood pressure measurements</strong> – Direct intra-arterial pressure monitoring is usually employed, although there are no studies demonstrating benefit compared with noninvasive blood pressure measurements. Arterial BP monitoring for descending aortic surgery is optimally established in the right arm for descending aortic surgery since the left innominate artery may be occluded if the stent covers the left subclavian artery. Also, the left arm may occasionally be used for vascular access.</p><p></p><p class="bulletIndent1">After deployment of the stent, the surgeon may wish to monitor distal limb pressure to check for adequate flow. Pressure tubing connected to the distal limb artery is passed from the sterile surgical field to the anesthesiologist, to be attached to a monitored pressure transducer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transesophageal echocardiography</strong> – Transesophageal echocardiography (TEE) is often used in thoracic aortic, emergency, or complex EVAR procedures to evaluate aortic anatomy (eg, atherosclerotic lesions, thrombi, dissection), assist with positioning and deployment of the endograft precisely at the target location, then confirm correct positioning, and detect endoleaks [<a href="#rid10">10-16</a>]. Use of TEE requires general anesthesia for patient comfort and preoperative assessment of esophageal pathology for safety.</p><p></p><p class="bulletIndent1">If hemodynamic instability develops, TEE can be used to rapidly determine the etiology by assessing:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systolic and diastolic ventricular function (see  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Ventricular function'</a>),</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adequacy of ventricular filling (ie, preload) (see  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Volume status'</a>), and</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vascular resistance (see  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Systemic vascular resistance'</a>)</p><p></p><p class="bulletIndent1">This information can then be used to guide decision-making about volume expansion, inotropic and/or vasopressor support, or vasodilator therapy [<a href="#rid17">17-19</a>].</p><p></p><p class="bulletIndent1">TEE is also used to monitor for new regional wall motion abnormalities, potentially providing a sensitive and specific indicator of myocardial ischemia  (<a class="graphic graphic_figure graphicRef65139" href="/d/graphic/65139.html" rel="external">figure 1</a>) [<a href="#rid20">20,21</a>]. However, there are no data demonstrating that TEE monitoring reduces risk of adverse perioperative cardiovascular events in patients undergoing vascular surgery [<a href="#rid6">6,17,22,23</a>]. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Major vascular surgery'</a>.)</p><p></p><p class="bulletIndent1">Further details regarding use of TEE monitoring during noncardiac surgery are presented elsewhere. (See  <a class="medical medical_review" href="/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central venous catheter (CVC)</strong> – It is usually unnecessary to measure central venous (or pulmonary artery) pressure or cardiac output, either invasively or noninvasively. However, large bore intravenous access must be obtained for either abdominal or thoracic EVAR procedures because of the possibility of hemorrhage and the need for transfusion. If obtaining such access is challenging, or use of vasoactive infusions is likely, the reliable vascular access and the information obtained with a CVC can be helpful, particularly in thoracic EVAR cases.</p><p></p><p class="headingAnchor" id="H868414020"><span class="h2">Neuromonitoring for spinal cord ischemia</span><span class="headingEndMark"> — </span>A surgical decision to use cerebrospinal fluid (CSF) drainage as a protective strategy to minimize spinal cord ischemia necessitates spinal cord monitoring with somatosensory evoked potentials (SSEPs) and/or motor evoked potentials (MEPs)  (<a class="graphic graphic_table graphicRef113806" href="/d/graphic/113806.html" rel="external">table 2</a>). (See <a class="local">'Monitoring and management of spinal cord ischemia'</a> below and  <a class="medical medical_review" href="/d/html/8191.html" rel="external">"Endovascular repair of the thoracic aorta", section on 'Minimizing spinal ischemia'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Somatosensory evoked potentials</strong> – Monitoring of SSEPs involves electrical stimulation of distal nerves of the lower extremity (eg, the posterior tibial and peroneal nerves), then recording the resultant cortical electrical potentials via scalp electrodes to monitor continuity of lateral and posterior column function  (<a class="graphic graphic_figure graphicRef101918" href="/d/graphic/101918.html" rel="external">figure 2</a>). (See  <a class="medical medical_review" href="/d/html/91216.html" rel="external">"Neuromonitoring in surgery and anesthesia", section on 'Somatosensory evoked potentials'</a>.)</p><p></p><p class="bulletIndent1">Considerations for anesthetic management when SSEPs are used to monitor for spinal cord ischemia are discussed separately [<a href="#rid24">24-26</a>]. (See  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery", section on 'Somatosensory evoked potentials (SSEPs)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Motor evoked potentials</strong> – Transcranial monitoring of MEPs involves electrical stimulation of the scalp overlying the motor cortex, which generates waves that travel down the corticospinal tract to the nerve root and the peripheral nerve, which results in muscle action potentials in a peripheral muscle group (eg, the anterior tibialis), where the evoked response is recorded  (<a class="graphic graphic_figure graphicRef101923" href="/d/graphic/101923.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/d/html/91216.html" rel="external">"Neuromonitoring in surgery and anesthesia", section on 'Motor evoked potentials'</a>.)</p><p></p><p class="bulletIndent1">Considerations for anesthetic management when MEPs are used to monitor for spinal cord ischemia are discussed separately [<a href="#rid24">24-26</a>]. (See  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery", section on 'Motor evoked potentials (MEPs)'</a>.)</p><p></p><p class="headingAnchor" id="H8715631"><span class="h1">ANESTHETIC MANAGEMENT</span><span class="headingEndMark"> — </span>EVAR has been performed safely with local anesthesia, neuraxial anesthesia, or general anesthesia [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H4225844652"><span class="h2">Anesthetic goals</span><span class="headingEndMark"> — </span>Anesthetic goals may vary according to surgical needs during EVAR but typically include:</p><p class="bulletIndent1"><span class="glyph">●</span>Facilitating the patient's ability to lie still comfortably for one to three hours</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assuring adequate hydration to reduce risk of contrast nephropathy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Managing anticoagulation (initiation, monitoring, and reversal)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Measuring serial hematocrits; preparation for massive transfusion (rare)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Controlling systemic blood pressure (BP), including administering pharmacologic agent(s) to rapidly decrease mean arterial pressure (MAP) when necessary (eg, at the time of device deployment)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Controlling temperature including active patient warming when necessary</p><p></p><p class="headingAnchor" id="H4274032084"><span class="h2">Anesthetic choices</span><span class="headingEndMark"> — </span>Thoracic or abdominal EVAR can be performed using local/regional anesthetic techniques together with monitored anesthesia care (MAC), neuraxial anesthesia, or general anesthesia. In all cases, the patient must remain immobile during positioning of modular graft components.</p><p>We prefer local/regional or neuraxial anesthesia for most EVAR procedures performed using routine surgical access to the aorta via the femoral or iliac arteries (see <a class="local">'Local/regional anesthesia'</a> below and <a class="local">'Neuraxial anesthesia'</a> below). As graft technology and imaging technology have evolved (eg, grafts have become smaller, more flexible, and are specifically designed for complex anatomy) and surgeon experience has increased, use of local/regional anesthesia with MAC is typically selected for primary repair candidates and is well-tolerated. For less common procedures requiring retroperitoneal vascular access via a 3 to 5 inch lower flank incision extended down to directly expose the iliac artery (eg, when direct access to the iliac artery is necessary due to femoral artery pathology), neuraxial or general anesthesia is typically necessary. General anesthesia may be selected for complex repairs that require extended duration to provide patient comfort and immobility.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential advantages of local/regional or neuraxial anesthesia</strong> – Compared with general anesthesia, potential advantages of these techniques in an awake patient include  (<a class="graphic graphic_table graphicRef134376" href="/d/graphic/134376.html" rel="external">table 3</a>) [<a href="#rid27">27,28</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Shorter intensive care unit (ICU) and hospital stays</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoidance of general anesthetics having myocardial depressant effects</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Less alteration of pulmonary mechanics</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Less catecholamine release because of avoidance of the sympathetic stimulation of laryngoscopy, as well as emergence excitation and the stimulation of extubation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early detection of anaphylactic and anaphylactoid reactions because of immediate complaint of symptoms (eg, pruritus due to hives; flushing; dyspnea; wheezing due to bronchospasm; stridor; swollen lips, tongue, and uvula; or syncope)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Detection of aneurysm rupture by the patient's report of retroperitoneal pain</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased intraoperative blood loss with neuraxial anesthesia, due to lower average mean arterial pressures</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Possible decreased in-hospital and 30-day mortality compared with general anesthesia, although these improved outcomes are only suggested in aggregate meta-analyses but not in direct randomized trials</p><p></p><p class="bulletIndent1">A summary of available data comparing local/regional or neuraxial anesthesia versus general anesthesia is presented:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Elective abdominal EVAR cases</strong> – For elective abdominal EVAR procedures, meta-analyses of randomized and nonrandomized studies suggest that local/regional or neuraxial anesthesia techniques are at least equivalent to general anesthesia, and may confer some benefit with respect to hospital length-of-stay and morbidity [<a href="#rid27">27-30</a>]. A 2020 meta-analysis that included 12 observational studies with 12,024 abdominal EVAR patients (1664 with local/regional anesthesia ad 10,360 with general anesthesia) noted shorter surgical time, shorter hospital stays in those receiving local/regional anesthesia, but no differences in 30-day mortality or in cardiac, renal, or vascular complications [<a href="#rid30">30</a>]. Similarly, a 2012 meta-analyses of abdominal EVAR cases that included 10 nonrandomized studies of 13,459 patients also noted shorter surgical times and hospital stays, with lower likelihood of ICU admission, but no differences in mortality for patients receiving local/regional or neuraxial anesthesia compared with those receiving general anesthesia [<a href="#rid29">29</a>]. In a review of 1206 abdominal EVAR cases (788 general anesthesia; 246 neuraxial anesthesia; 82 local/regional anesthesia), there were no differences among groups in surgical time, length-of-stay, or morbidity or mortality [<a href="#rid31">31</a>]. Interpretation of data from these studies is limited by the absence of randomized trials, as well as the small total number of events and heterogeneity among studies (eg, nonstandardized anesthetic techniques, inclusion of emergencies in some studies).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Emergency abdominal EVAR cases</strong> – For emergency EVAR repair of ruptured abdominal aortic aneurysm, a 2021 meta-analysis included eight studies with 3116 patients; 867 received local/regional anesthesia, while 2249 received general anesthesia [<a href="#rid28">28</a>]. Lower mortality (in-hospital plus 30-day) was noted in the local/regional anesthesia group compared with the general anesthesia group (16.4 versus 25.4 percent, unadjusted odds ratio [OR] 0.47, 95% CI 0.32-0.68). In a 2018 meta-analysis that included 39,744 patients from 22 nonrandomized studies undergoing either elective or emergency abdominal EVAR, local/regional anesthesia appeared to confer lower risk for 30-day mortality in emergency abdominal EVAR cases compared with general anesthesia, but the trends in elective surgery were less clear [<a href="#rid27">27</a>]. Notably, mortality did not differ in comparisons between neuraxial versus general, or neuraxial versus local anesthesia in this study.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Thoracic EVAR cases</strong> – Similarly, for thoracic EVAR, there are no randomized trials comparing anesthetic techniques. In one single-center prospective study that included 400 consecutive elective or emergency thoracic EVAR cases, multivariate analysis revealed that general anesthesia was a risk factor for mortality compared with neuraxial anesthesia (hazard ratio [HR] 1.59, 95% CI 1.02-2.50) [<a href="#rid32">32</a>]. Selection bias was likely since general anesthesia was used most commonly in this center's early experience, but with increasing experience, general anesthesia was used only when the patient was unable to cooperate during the procedure. Also, changes in stent technology (eg, decreased size and increased flexibility) have improved the likelihood of success with local or neuraxial anesthesia in the years since this study was performed [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/8191.html" rel="external">"Endovascular repair of the thoracic aorta"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Potential advantages of general anesthesia</strong> – General anesthesia has advantages and may be preferred for patients with  (<a class="graphic graphic_table graphicRef134376" href="/d/graphic/134376.html" rel="external">table 3</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elimination of concerns regarding anxiety, claustrophobia, discomfort, and/or ability to remain motionless and cooperate</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elimination of concerns regarding inability to lay flat due to significant chronic obstructive pulmonary disease, congestive heart failure, back pain, or other reasons</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Less risk of patient movement during painful stimuli (eg, during manipulation of sheaths or device delivery systems inside the iliac vessels or ischemic limb pain caused by prolonged attempts at contralateral limb cannulation)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complete and satisfactory suspension of respiration during stent deployment</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased bowel peristalsis if opioids are administered in sufficient doses [<a href="#rid33">33</a>], which may improve the quality of intraoperative imaging</p><p></p><p>Notably, conversion from regional or neuraxial anesthesia to general anesthesia occasionally becomes necessary. Notably, with increasing experience and improving technology, intraoperative conversion from EVAR to open aortic repair is less than 1 percent. However, emergency conversion to general anesthesia rarely occurs due to aneurysm rupture, vascular injury, or inability to deliver or seal the device (ie, endoleak), but in many reports the incidence of conversion is zero [<a href="#rid34">34,35</a>].</p><p class="headingAnchor" id="H1839571713"><span class="h2">Specific anesthetic techniques</span></p><p class="headingAnchor" id="H342515236"><span class="h3">Local/regional anesthesia</span><span class="headingEndMark"> — </span>Femoral or iliac arterial access to accomplish EVAR is accomplished with skin infiltration with local anesthetic. MAC is provided by the anesthesiologist. Short-acting agents such as <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> boluses, an opioid (eg, infusion of <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>), or infusion of a sedative-hypnotic agent such as <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> may be administered to provide sedation, analgesia, and/or anxiolysis as necessary, but allow rapid recovery. Notably, progression from a "light," level of sedation to "deep," sedation (or unconsciousness) can occur suddenly, particularly in the older patient. Vigilant monitoring and constant communication with the patient is required to avoid airway obstruction, hypoxemia, or aspiration.</p><p>Although placement of older devices with a much larger diameter occasionally required supplementation by ilioinguinal and iliohypogastric nerve blocks [<a href="#rid36">36</a>], this is rarely necessary with the smaller, more flexible grafts that are currently used. Bilateral transversus abdominis plane blocks have also been successfully used as analgesia adjuvants in the past [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/121447.html" rel="external">"Abdominal nerve block techniques", section on 'Ilioinguinal and iliohypogastric nerve block'</a> and  <a class="medical medical_review" href="/d/html/122399.html" rel="external">"Transversus abdominis plane (TAP) blocks procedure guide"</a>.)</p><p class="headingAnchor" id="H342515322"><span class="h3">Neuraxial anesthesia</span><span class="headingEndMark"> — </span>Effective neuraxial anesthetic techniques include single-dose spinal, continuous spinal, or epidural anesthesia. The typical goal is to provide neuraxial anesthesia at dermatomal levels T6 through L3, lasting three to four hours [<a href="#rid37">37</a>]. If hypotension develops due to sympathetic blockade after a neuraxial block, this should be immediately treated to avoid insufficient myocardial or cerebral blood flow since many patients undergoing EVAR have concomitant coronary or cerebrovascular atherosclerotic disease (see <a class="local">'Hemodynamic management'</a> below). Short-acting agents providing a "light," level of sedation may be administered to supplement the neuraxial anesthetic, similar to MAC for patients who have local/regional anesthesia. (See <a class="local">'Local/regional anesthesia'</a> above.)</p><p class="headingAnchor" id="H191378461"><span class="h3">General anesthesia</span><span class="headingEndMark"> — </span>For general anesthesia, anesthetic agents and dosing are selected with the primary goad of avoiding (or immediately treating) significant fluctuations in BP. (See <a class="local">'Hemodynamic management'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction</strong> – Induction is similar to that for patients undergoing open abdominal aortic aneurysm surgery or other patients with likely ischemic heart disease undergoing noncardiac surgery. (See  <a class="medical medical_review" href="/d/html/94260.html" rel="external">"Anesthesia for open abdominal aortic surgery", section on 'Induction'</a> and  <a class="medical medical_review" href="/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Induction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maintenance</strong> – Goals during maintenance of anesthesia are to maintain hemodynamic stability while avoiding interference from anesthetic agents with any neuromonitoring techniques if these are planned. Maintenance of anesthesia can be achieved with a volatile anesthetic agent, a total intravenous (IV) anesthetic technique, or with a combination of volatile and IV agents. Details are discussed in separate topics. (See  <a class="medical medical_review" href="/d/html/91216.html" rel="external">"Neuromonitoring in surgery and anesthesia", section on 'Anesthetic effects on neuromonitoring'</a> and  <a class="medical medical_review" href="/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Maintenance'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergence</strong> – Goals during emergence from general anesthesia are to maintain hemodynamic control and avoid wide swings in BP as anesthetic agents are discontinued and the trachea is extubated. Administration of a short-acting beta blocker (eg, <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a>) and/or vasodilator (eg, <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a>, <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="9707" href="/d/drug information/9707.html" rel="external">nitroprusside</a>) is often necessary to blunt the transient sympathetic stimulation that occurs during arousal and extubation. (See <a class="local">'Hemodynamic management'</a> below.)</p><p></p><p class="headingAnchor" id="H93095370"><span class="h2">Fluid and blood management</span><span class="headingEndMark"> — </span>Restoring and maintaining adequate intravascular volume status is accomplished with IV crystalloid (ie, normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or a balanced isotonic crystalloid solution) administered before, during, and continuing for several hours after contrast administration to reduce the risk of contrast-induced nephropathy (CIN). (See  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Crystalloid solutions'</a>.)</p><p>If angiography with contrast has been performed shortly before urgent surgery, measures to avoid CIN include avoidance of intravascular volume depletion. Typically, for outpatients undergoing contrast angiography, 3 mL/kg of IV crystalloid solution is administered over one hour preprocedure, then 1 to 1.5 mL/kg/hour is administered during and for four to six hours after angiography. For inpatients, 1 mL/kg/hour is administered for 6 to 12 hours preprocedure, then for 6 to 12 hours during and after angiography. Normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or a balanced isotonic crystalloid solution is typically selected rather than <a class="drug drug_general" data-topicid="9928" href="/d/drug information/9928.html" rel="external">sodium bicarbonate</a> because bicarbonate provides no additional benefit to saline, needs to be compounded, and is more expensive [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/7221.html" rel="external">"Prevention of contrast-associated acute kidney injury related to angiography", section on 'Fluid administration'</a> and  <a class="medical medical_review" href="/d/html/7221.html" rel="external">"Prevention of contrast-associated acute kidney injury related to angiography", section on 'Saline versus bicarbonate'</a>.)</p><p>If angiography was not performed, the calculated fluid deficit is quickly replaced at the beginning of the procedure (see  <a class="medical medical_review" href="/d/html/14942.html" rel="external">"Intraoperative fluid management", section on 'Hypovolemia'</a>). The duration of administration of fluid should be directly proportional to the degree of renal impairment (ie, longer for individuals with more severe renal impairment). Mild hypervolemia (approximately 5 ml/kg ideal body weight positive fluid balance) may be helpful to avoid increases in serum creatinine in patients without congestive heart failure or ejection fraction &lt;40 percent [<a href="#rid39">39</a>].</p><p>Similar to other surgical procedures, we transfuse autologous, salvaged, or allogeneic red blood cells when hemoglobin is &lt;7 to 8 g/dL (approximately equivalent to a hematocrit ≤21 to 24 percent). We use a higher target of &lt;9 to 10 g/dL in selected patients with increased risk of spinal cord malperfusion or if myocardial or spinal cord ischemia is detected [<a href="#rid40">40</a>]. (See <a class="local">'Monitoring and management of spinal cord ischemia'</a> below and  <a class="medical medical_review" href="/d/html/112610.html" rel="external">"Intraoperative transfusion and administration of clotting factors", section on 'Red blood cells'</a>.)</p><p class="headingAnchor" id="H1880850"><span class="h2">Hemodynamic management</span><span class="headingEndMark"> — </span>Generally, we maintain systolic and mean arterial BP values within 20 percent of the patient's baseline, with a MAP of not less than 90 mmHg when there are concerns for spinal cord perfusion based on prior thoracic aortic replacement and/or data from ongoing SSEP monitoring [<a href="#rid40">40</a>]. Hypotension with systolic BP &lt;90 mmHg or &lt;40 percent below preoperative levels for ≥10 minutes is avoided, as this may contribute to development of postoperative renal insufficiency [<a href="#rid41">41</a>], or insufficient myocardial or cerebral blood flow in these patients who often have concomitant coronary or cerebrovascular atherosclerotic disease. We also avoid any hypertensive episodes which may cause aneurysm rupture. (See  <a class="medical medical_review" href="/d/html/94532.html" rel="external">"Hemodynamic management during anesthesia in adults", section on 'Blood pressure targets'</a> and  <a class="medical medical_review" href="/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Prevention of ischemia'</a>.) [<a href="#rid42">42,43</a>].</p><p>The anesthesiologist should have sympathomimetic, vasodilator, and short-acting beta blocker medications readily available throughout the perioperative period to rapidly treat hypotension or hypertension, or arrhythmias. Specifically, we suggest that bolus doses of the following drugs be immediately available: <a class="drug drug_general" data-topicid="9768" href="/d/drug information/9768.html" rel="external">phenylephrine</a> (eg, 100 mcg/mL, administered in 100 to 200 mcg boluses), <a class="drug drug_general" data-topicid="9114" href="/d/drug information/9114.html" rel="external">ephedrine</a> (eg, 5 to 10 mg/mL, administered in 5 to 20 mg boluses), <a class="drug drug_general" data-topicid="10039" href="/d/drug information/10039.html" rel="external">vasopressin</a> (eg, 1 unit/mL, administered in 1 unit boluses), <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a> (eg, 100 mcg/mL, administered in 100 to 500 mcg boluses), <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">labetalol</a> (eg, 5 to 10 mg/mL, administered in 5 to 20 mg boluses), <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> (10 mg, administered in 10 to 50 mg boluses), and <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a> (0.4 mg/mL, administered as 0.2 to 0.4 mg boluses). In addition, we prepare infusion solutions of a vasopressor and a vasodilator that are immediately available to administer (eg, phenylephrine and nicardipine or <a class="drug drug_general" data-topicid="9706" href="/d/drug information/9706.html" rel="external">nitroglycerin</a>  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef119750" href="/d/graphic/119750.html" rel="external">table 5</a>)). (See  <a class="medical medical_review" href="/d/html/141346.html" rel="external">"Intraoperative use of vasoactive agents", section on 'Vasopressor and positive inotropic agents'</a> and  <a class="medical medical_review" href="/d/html/141346.html" rel="external">"Intraoperative use of vasoactive agents", section on 'Antihypertensive agents'</a>.)</p><p class="headingAnchor" id="H2708205054"><span class="h3">Considerations during device deployment</span><span class="headingEndMark"> — </span>At the time of device deployment, the anesthesiologist may be asked to lower mean arterial BP to decrease the risk of distal migration of the stent. This may be accomplished with administration of short-acting anesthetic agents such as <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> in 10 to 30 mg increments, or short-acting vasoactive agents such as <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> 10 to 30 mg or <a class="drug drug_general" data-topicid="9697" href="/d/drug information/9697.html" rel="external">nicardipine</a> 100 to 200 mcg. Furthermore, ventilation is transiently stopped at the time of device deployment in anesthetized patient (or awake patients are asked to hold their breath).</p><p class="headingAnchor" id="H2285384967"><span class="h2">Management of anticoagulation</span><span class="headingEndMark"> — </span>Prior to insertion of the endovascular graft device, systemic anticoagulation is initiated, typically with an IV heparin dose of 5000 to 8000 units. The goal is an activated coagulation time (ACT) of 200 seconds or greater. After device deployment, anticoagulation is reversed and the ACT is rechecked.</p><p>After insertion of the graft, thrombus in the aortic aneurysm remains in contact with the general circulation due to back bleeding of the lumbar arteries and other aortic branches around or through the graft, and back into the aneurysm. This thrombus has the potential to induce consumption of the coagulation factors and platelets. However, studies have noted only mild perturbations in the coagulation pathway after EVAR (eg, a decrease in platelet count or an increase in fibrin degradation products), while no cases of disseminated intravascular coagulation have been reported in this setting [<a href="#rid44">44,45</a>]. (See  <a class="medical medical_review" href="/d/html/16918.html" rel="external">"Complications of endovascular abdominal aortic repair", section on 'Endoleak'</a>.)</p><p class="headingAnchor" id="H3647530029"><span class="h2">Temperature management</span><span class="headingEndMark"> — </span>Hypothermia is prevented by using convective warming devices (eg, forced air warmers) and administering warmed IV fluids. Management of hypothermia continues into the postoperative period as necessary. (See  <a class="medical medical_review" href="/d/html/94588.html" rel="external">"Perioperative temperature management"</a>.)</p><p class="headingAnchor" id="H383873913"><span class="h2">Monitoring and management of spinal cord ischemia</span></p><p class="headingAnchor" id="H2949028930"><span class="h3">Procedure-related risks</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abdominal EVAR</strong> – The risk of spinal cord ischemia in elective abdominal EVAR in patients without prior thoracic aortic aneurysm repair is estimated to be 0.3 percent [<a href="#rid46">46</a>]. Since there are risks with lumbar cerebrospinal fluid (CSF) drainage including epidural hematoma [<a href="#rid47">47,48</a>], the technique is rarely used in abdominal EVAR cases. Although the technique may be considered in patients with prior repair of aortic aneurysm in a different aortic location such as a large descending thoracic aneurysm [<a href="#rid49">49</a>], one study found no increased risk in patients having abdominal EVAR after prior thoracic EVAR [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thoracic EVAR</strong> – Spinal cord ischemia is also rare in patients undergoing thoracic EVAR (&lt;3 percent); this incidence is similar to risks incurred with CSF drain placement [<a href="#rid51">51</a>]. A 2011 literature review found only six case reports [<a href="#rid52">52</a>]. However, the extent of the aorta that is covered by endograft is considered since risk increases if the length of aortic coverage is &gt;20 cm [<a href="#rid53">53,54</a>], as is prior repair of abdominal aortic aneurysm [<a href="#rid55">55</a>]. One study reported that patients undergoing thoracic EVAR after prior abdominal EVAR had an incidence of spinal cord ischemia in 14.3 percent [<a href="#rid55">55</a>]. Risk is greatest if the artery of Adamkiewicz was previously excluded since that artery supplies most of the flow to the lower one-third of the anterior spinal artery.</p><p></p><p class="headingAnchor" id="H1884286892"><span class="h3">Specific management techniques</span><span class="headingEndMark"> — </span>For patients with complex aortic aneurysms undergoing EVAR after prior thoracic aortic surgery (and thus increased risk of spinal cord malperfusion), the most common practices to prevent spinal cord ischemia include BP elevation to a MAP of not less than 90 mmHg in the perioperative period and ensuring a hemoglobin goal of not less than 10 g/dL; treatment of evidence of spinal cord ischemia also includes placement of a CSF drain  (<a class="graphic graphic_table graphicRef113806" href="/d/graphic/113806.html" rel="external">table 2</a>) [<a href="#rid40">40,56</a>]. Details of monitoring and management are discussed separately. (See  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery", section on 'Neuromonitoring for spinal cord ischemia'</a> and  <a class="medical medical_review" href="/d/html/94266.html" rel="external">"Anesthesia for open descending thoracic aortic surgery", section on 'Cerebrospinal fluid (CSF) pressure monitoring'</a>.)</p><p class="headingAnchor" id="H191376972"><span class="h1">POSTOPERATIVE ANESTHETIC CARE</span><span class="headingEndMark"> — </span>After completion of the EVAR, the patient is transferred to the post-anesthesia care unit regardless of whether general anesthesia, neuraxial anesthesia, or intravenous (IV) sedation was employed, for recovery from sedation and monitoring for myocardial or spinal cord ischemia. Management in an intensive care unit (ICU) is appropriate for some patients (eg, high risk for cardiovascular, pulmonary, renal, bleeding, or spinal cord complications). (See  <a class="medical medical_review" href="/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm", section on 'Postoperative care'</a> and  <a class="medical medical_review" href="/d/html/16918.html" rel="external">"Complications of endovascular abdominal aortic repair"</a>.)</p><p>Notably, spinal cord ischemia and paraplegia can present hours or even several days after open aortic repair or EVAR  (<a class="graphic graphic_algorithm graphicRef51097" href="/d/graphic/51097.html" rel="external">algorithm 1</a>) [<a href="#rid52">52</a>]. In high-risk cases, a systematic approach may be employed that includes frequent neurologic assessment, arterial pressure augmentation, somatosensory evoked potential (SSEP) monitoring, cerebrospinal fluid (CSF) drainage if necessary to treat developing neurologic deficits, and imaging the spine using computed tomography or magnetic resonance imaging [<a href="#rid40">40,56-58</a>]. (See  <a class="medical medical_review" href="/d/html/1115.html" rel="external">"Spinal cord infarction: Treatment and prognosis", section on 'Following aortic surgery or endovascular repair'</a>.)</p><p>However, since spinal cord ischemia is rare after EVAR procedures (see <a class="local">'Procedure-related risks'</a> above), most clinicians choose to wait for neurologic deficits to develop, and then intervene with immediate placement of a CSF drain [<a href="#rid40">40</a>]. This approach balances the risk of placement of an intrathecal catheter for CSF drainage with the rarity of development of postoperative paraparesis or paraplegia [<a href="#rid47">47</a>]. In one institution, detection and treatment of spinal cord ischemia using this approach in patients undergoing EVAR for a descending thoracic aneurysm limited permanent neurologic deficit to 2.7 percent, although 6.6 percent of patients had evidence of postoperative spinal cord ischemia [<a href="#rid58">58</a>]. Although having a CSF drain already in place may improve chances for good neurologic outcome in patients with delayed spinal cord ischemia [<a href="#rid59">59</a>], prophylactic use of CSF drainage undergoing thoracic EVAR is associated with moderate risk and questionable benefit [<a href="#rid54">54,60</a>].</p><p class="headingAnchor" id="H1247461617"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118036.html" rel="external">"Society guideline links: Aortic and other peripheral aneurysms"</a> and  <a class="medical medical_society_guidelines" href="/d/html/118034.html" rel="external">"Society guideline links: Aortic dissection and other acute aortic syndromes"</a>.)</p><p class="headingAnchor" id="H383874081"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthetic assessment</strong> – Most patients with thoracic and/or abdominal aortic aneurysm are older and have major cardiovascular and other comorbidities, as well as risk of contrast-induced nephropathy (CIN) if angiography was recent. (See <a class="local">'Preanesthetic assessment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We obtain a preoperative electrocardiogram (ECG) as a useful baseline if the postoperative ECG is abnormal. We perform additional cardiac testing in selected patients with changes in cardiac symptoms and functional status.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We obtain a creatinine level in the immediate preoperative period to compare with previous measurements. In consultation with a nephrologist, we ensure that sufficient time is allowed between the last contrast dye load and the time of the currently planned procedure.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We continue chronically administered beta-blockers, statins, and antihypertensives in the perioperative period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring considerations</strong> – In addition to standard monitoring  (<a class="graphic graphic_table graphicRef110080" href="/d/graphic/110080.html" rel="external">table 1</a>), specialized monitoring includes:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular monitoring (See <a class="local">'Cardiovascular monitoring'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Direct intra-arterial pressure monitoring is optimally established in the right arm for descending aortic surgery since the left innominate artery may be occluded if the stent covers the left subclavian artery.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Transesophageal echocardiography (TEE), often used in thoracic aortic, emergency, or complex endovascular aortic repair (EVAR) procedures to evaluate aortic anatomy (eg, atherosclerotic lesions, thrombi, dissection), confirm correct positioning of grafts and stents, and detect endoleaks. Use of TEE requires general anesthesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neuromonitoring – A surgical decision to use cerebrospinal fluid (CSF) drainage as a protective strategy to minimize spinal cord ischemia  (<a class="graphic graphic_table graphicRef113806" href="/d/graphic/113806.html" rel="external">table 2</a>) necessitates spinal cord monitoring with somatosensory evoked potentials (SSEPs  (<a class="graphic graphic_figure graphicRef101918" href="/d/graphic/101918.html" rel="external">figure 2</a>)) and/or motor evoked potentials (MEPs)  (<a class="graphic graphic_figure graphicRef101923" href="/d/graphic/101923.html" rel="external">figure 3</a>). (See <a class="local">'Neuromonitoring for spinal cord ischemia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthetic choices</strong> – Thoracic or abdominal EVAR can be performed using local/regional anesthetic techniques together with monitored anesthesia care (MAC), neuraxial anesthesia, or general anesthesia  (<a class="graphic graphic_table graphicRef134376" href="/d/graphic/134376.html" rel="external">table 3</a>). In all cases, the patient must remain immobile during positioning of modular graft components. (See <a class="local">'Anesthetic goals'</a> above.)</p><p></p><p class="bulletIndent1">We suggest local/regional or neuraxial anesthesia for most EVAR procedures performed using routine surgical access to the aorta via the femoral or iliac arteries (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). For less common procedures requiring retroperitoneal vascular access via a 3 to 5 inch lower flank incision extended down to directly expose the iliac artery, neuraxial or general anesthesia is typically necessary. General anesthesia may be selected for complex repairs that require extended duration to provide patient comfort and immobility. (See <a class="local">'Anesthetic choices'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Local/regional anesthesia</strong> – For local/regional anesthesia, skin infiltration with local anesthetic may be supplemented with short-acting agents such as <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> boluses, an opioid (eg, infusion of <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>), or infusion of a sedative-hypnotic agent such as <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> to provide sedation and/or analgesia as part of MAC. (See <a class="local">'Local/regional anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuraxial anesthesia</strong> – Effective neuraxial anesthetic techniques include single-dose spinal, continuous spinal, or epidural anesthesia. Hypotension due to sympathetic blockade should be immediately treated. Supplemental sedation and/or analgesia with short-acting agents may be administered if needed. (See <a class="local">'Neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General anesthesia</strong> – For general anesthesia, anesthetic agents and dosing are selected with the primary goal of avoiding significant fluctuations in blood pressure (BP), as well as avoiding interference with neuromonitoring techniques (if used). (See <a class="local">'General anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fluid and blood management</strong> – Restoring and maintaining adequate intravascular volume status with intravenous (IV) crystalloid (ie, normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or a balanced isotonic crystalloid solution) administered before, during, and continuing for several hours after contrast administration reduces the risk of CIN. We transfuse red blood cells when hemoglobin is &lt;7 to 8 g/dL, with a higher hemoglobin target of &lt;9 to 10 g/dL in selected high-risk patients or if myocardial or spinal cord ischemia is detected. (See <a class="local">'Fluid and blood management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong> – Generally, we maintain systolic and mean arterial BP values within 20 percent of the patient's baseline, with a mean arterial pressure (MAP) of not less than 90 mmHg  (<a class="graphic graphic_table graphicRef119747" href="/d/graphic/119747.html" rel="external">table 4</a>). We also avoid any hypertensive episodes which may cause aneurysm rupture. At the time of device deployment, a lower MAP may be achieved with administration of short-acting anesthetic agents or short-acting vasoactive agents  (<a class="graphic graphic_table graphicRef119750" href="/d/graphic/119750.html" rel="external">table 5</a>). (See <a class="local">'Hemodynamic management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anticoagulation management</strong> – Prior to insertion of the endovascular graft device, systemic anticoagulation is initiated, typically with an IV heparin dose of 5000 to 8000 units. The goal is an activated coagulation time (ACT) of 200 seconds or greater. After device deployment, anticoagulation is reversed and the ACT is rechecked. (See <a class="local">'Management of anticoagulation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of spinal cord ischemia</strong> – Perioperative rescue maneuvers for evidence of spinal cord ischemia include BP elevation to a MAP of not less than 90 mmHg, ensuring a hemoglobin goal of not less than 10 mg/dL, and placement of a CSF drain  (<a class="graphic graphic_table graphicRef113806" href="/d/graphic/113806.html" rel="external">table 2</a> and <a class="graphic graphic_algorithm graphicRef51097" href="/d/graphic/51097.html" rel="external">algorithm 1</a>). (See <a class="local">'Monitoring and management of spinal cord ischemia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative considerations</strong> – Transfer to the post-anesthesia care unit (or intensive care unit [ICU]) is necessary regardless of whether general anesthesia, neuraxial anesthesia, or IV sedation was employed, for recovery from sedation and monitoring for myocardial or spinal cord ischemia. (See <a class="local">'Postoperative anesthetic care'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Upchurch GR Jr, Escobar GA, Azizzadeh A, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg 2021; 73:55S.</a></li><li><a class="nounderline abstract_t">Fort ACP, Rubin LA, Meltzer AJ, et al. Perioperative Management of Endovascular Thoracoabdominal Aortic Aneurysm Repair. J Cardiothorac Vasc Anesth 2017; 31:1440.</a></li><li><a class="nounderline abstract_t">Schermerhorn ML, O'Malley AJ, Jhaveri A, et al. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 2008; 358:464.</a></li><li><a class="nounderline abstract_t">Lederle FA, Kyriakides TC, Stroupe KT, et al. Open versus Endovascular Repair of Abdominal Aortic Aneurysm. N Engl J Med 2019; 380:2126.</a></li><li><a class="nounderline abstract_t">Kristensen SD, Knuuti J. New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014; 35:2344.</a></li><li><a class="nounderline abstract_t">Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:2215.</a></li><li><a class="nounderline abstract_t">Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014; 64:e77.</a></li><li><a class="nounderline abstract_t">Cuypers PW, Buth J. Does endovascular aortic aneurysm repair justify a reduced cardiology work-up? J Cardiovasc Surg (Torino) 2003; 44:437.</a></li><li><a class="nounderline abstract_t">Chou J, Ma M, Gylys M, et al. Preexisting Right Ventricular Dysfunction Is Associated With Higher Postoperative Cardiac Complications and Longer Hospital Stay in High-Risk Patients Undergoing Nonemergent Major Vascular Surgery. J Cardiothorac Vasc Anesth 2019; 33:1279.</a></li><li><a class="nounderline abstract_t">Swaminathan M, Lineberger CK, McCann RL, Mathew JP. The importance of intraoperative transesophageal echocardiography in endovascular repair of thoracic aortic aneurysms. Anesth Analg 2003; 97:1566.</a></li><li><a class="nounderline abstract_t">Fattori R, Caldarera I, Rapezzi C, et al. Primary endoleakage in endovascular treatment of the thoracic aorta: importance of intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg 2000; 120:490.</a></li><li><a class="nounderline abstract_t">Rocchi G, Lofiego C, Biagini E, et al. Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection. J Vasc Surg 2004; 40:880.</a></li><li><a class="nounderline abstract_t">Rapezzi C, Rocchi G, Fattori R, et al. Usefulness of transesophageal echocardiographic monitoring to improve the outcome of stent-graft treatment of thoracic aortic aneurysms. Am J Cardiol 2001; 87:315.</a></li><li><a class="nounderline abstract_t">Gonzalez-Fajardo JA, Gutierrez V, San Roman JA, et al. Utility of intraoperative transesophageal echocardiography during endovascular stent-graft repair of acute thoracic aortic dissection. Ann Vasc Surg 2002; 16:297.</a></li><li><a class="nounderline abstract_t">Swaminathan M, Mackensen GB, Podgoreanu MV, et al. Spontaneous echocardiographic contrast indicating successful endoleak management. Anesth Analg 2007; 104:1037.</a></li><li><a class="nounderline abstract_t">Knight JB, Chaer RA, Gelzinis TA. Transesophageal Echocardiography for Guidance of Endovascular Stent Exclusion of Thoracic Aortic Thrombi: A Case Series. J Cardiothorac Vasc Anesth 2018; 32:1333.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112:1084.</a></li><li><a class="nounderline abstract_t">Porter TR, Shillcutt SK, Adams MS, et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2015; 28:40.</a></li><li><a class="nounderline abstract_t">Reeves ST, Finley AC, Skubas NJ, et al. Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 2013; 117:543.</a></li><li><a class="nounderline abstract_t">Gaibazzi N, Rigo F, Lorenzoni V, et al. Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography. JACC Cardiovasc Imaging 2013; 6:1.</a></li><li><a class="nounderline abstract_t">Koolen JJ, Visser CA, Reichert SL, et al. Improved monitoring of myocardial ischaemia during major vascular surgery using transoesophageal echocardiography. Eur Heart J 1992; 13:1028.</a></li><li><a class="nounderline abstract_t">London MJ, Tubau JF, Wong MG, et al. The "natural history" of segmental wall motion abnormalities in patients undergoing noncardiac surgery. S.P.I. Research Group. Anesthesiology 1990; 73:644.</a></li><li><a class="nounderline abstract_t">Eisenberg MJ, London MJ, Leung JM, et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268:210.</a></li><li><a class="nounderline abstract_t">Sloan TB, Jameson LC. Electrophysiologic monitoring during surgery to repair the thoraco-abdominal aorta. J Clin Neurophysiol 2007; 24:316.</a></li><li><a class="nounderline abstract_t">Nuwer MR, Emerson RG, Galloway G, et al. Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology 2012; 78:585.</a></li><li><a class="nounderline abstract_t">Nuwer MR, Emerson RG, Galloway G, et al. Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials*. J Clin Neurophysiol 2012; 29:101.</a></li><li><a class="nounderline abstract_t">Armstrong RA, Squire YG, Rogers CA, et al. Type of Anesthesia for Endovascular Abdominal Aortic Aneurysm Repair. J Cardiothorac Vasc Anesth 2019; 33:462.</a></li><li><a class="nounderline abstract_t">Deng J, Liu J, Rong D, et al. A meta-analysis of locoregional anesthesia versus general anesthesia in endovascular repair of ruptured abdominal aortic aneurysm. J Vasc Surg 2021; 73:700.</a></li><li><a class="nounderline abstract_t">Karthikesalingam A, Thrumurthy SG, Young EL, et al. Locoregional anesthesia for endovascular aneurysm repair. J Vasc Surg 2012; 56:510.</a></li><li><a class="nounderline abstract_t">Harky A, Ahmad MU, Santoro G, et al. Local Versus General Anesthesia in Nonemergency Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth 2020; 34:1051.</a></li><li><a class="nounderline abstract_t">Cheng M, Chen Q, Tran-McCaslin M, et al. Endovascular Abdominal Aortic Aneurysm Repair: Does Anesthesia Type Matter? Ann Vasc Surg 2019; 61:284.</a></li><li><a class="nounderline abstract_t">Lee WA, Daniels MJ, Beaver TM, et al. Late outcomes of a single-center experience of 400 consecutive thoracic endovascular aortic repairs. Circulation 2011; 123:2938.</a></li><li><a class="nounderline abstract_t">Lin YM, Tang Y, Fu Y, et al. An opioid receptor-independent mechanism underlies motility dysfunction and visceral hyperalgesia in opioid-induced bowel dysfunction. Am J Physiol Gastrointest Liver Physiol 2021; 320:G1093.</a></li><li><a class="nounderline abstract_t">Jankovic Z, Ahmad N, Ravishankar N, Archer F. Transversus abdominis plane block: how safe is it? Anesth Analg 2008; 107:1758.</a></li><li><a class="nounderline abstract_t">Edwards MS, Andrews JS, Edwards AF, et al. Results of endovascular aortic aneurysm repair with general, regional, and local/monitored anesthesia care in the American College of Surgeons National Surgical Quality Improvement Program database. J Vasc Surg 2011; 54:1273.</a></li><li><a class="nounderline abstract_t">Lippmann M, Lingam K, Rubin S, et al. Anesthesia for endovascular repair of abdominal and thoracic aortic aneurysms: a review article. J Cardiovasc Surg (Torino) 2003; 44:443.</a></li><li><a class="nounderline abstract_t">Aadahl P, Lundbom J, Hatlinghus S, Myhre HO. Regional anesthesia for endovascular treatment of abdominal aortic aneurysms. J Endovasc Surg 1997; 4:56.</a></li><li><a class="nounderline abstract_t">Weisbord SD, Gallagher M, Jneid H, et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 2018; 378:603.</a></li><li><a class="nounderline abstract_t">Waheed S, Choi MJ. Trials and tribulations of diagnosing and preventing contrast-induced acute kidney injury. J Thorac Cardiovasc Surg 2021; 162:1581.</a></li><li><a class="nounderline abstract_t">Aucoin VJ, Eagleton MJ, Farber MA, et al. Spinal cord protection practices used during endovascular repair of complex aortic aneurysms by the U.S. Aortic Research Consortium. J Vasc Surg 2021; 73:323.</a></li><li><a class="nounderline abstract_t">Walker SR, Yusuf SW, Wenham PW, Hopkinson BR. Renal complications following endovascular repair of abdominal aortic aneurysms. J Endovasc Surg 1998; 5:318.</a></li><li><a class="nounderline abstract_t">Brown OW, Hollier LH, Pairolero PC, et al. Abdominal aortic aneurysm and coronary artery disease. Arch Surg 1981; 116:1484.</a></li><li><a class="nounderline abstract_t">Hammond EC, Garfinkel L. Coronary heart disease, stroke, and aortic aneurysm. Arch Environ Health 1969; 19:167.</a></li><li><a class="nounderline abstract_t">Mialhe C, Amicabile C, Becquemin JP. Endovascular treatment of infrarenal abdominal aneurysms by the Stentor system: preliminary results of 79 cases. Stentor Retrospective Study Group. J Vasc Surg 1997; 26:199.</a></li><li><a class="nounderline abstract_t">Shimazaki T, Ishimaru S, Kawaguchi S, et al. Blood coagulation and fibrinolytic response after endovascular stent grafting of thoracic aorta. J Vasc Surg 2003; 37:1213.</a></li><li><a class="nounderline abstract_t">Gravereaux EC, Faries PL, Burks JA, et al. Risk of spinal cord ischemia after endograft repair of thoracic aortic aneurysms. J Vasc Surg 2001; 34:997.</a></li><li><a class="nounderline abstract_t">Rong LQ, Kamel MK, Rahouma M, et al. Cerebrospinal-fluid drain-related complications in patients undergoing open and endovascular repairs of thoracic and thoraco-abdominal aortic pathologies: a systematic review and meta-analysis. Br J Anaesth 2018; 120:904.</a></li><li><a class="nounderline abstract_t">Awad H, Huang TJ, Tili E, Bourekas E. Images in Anesthesiology: Spinal Subdural Hematoma after Spinal Drain for Endovascular Thoracic Aortic Aneurysm Repair. Anesthesiology 2018; 128:1004.</a></li><li><a class="nounderline abstract_t">Ullery BW, Wang GJ, Low D, Cheung AT. Neurological complications of thoracic endovascular aortic repair. Semin Cardiothorac Vasc Anesth 2011; 15:123.</a></li><li><a class="nounderline abstract_t">Ullery BW, Wang GJ, Woo EY, et al. No increased risk of spinal cord ischemia in delayed AAA repair following thoracic aortic surgery. Vasc Endovascular Surg 2013; 47:85.</a></li><li><a class="nounderline abstract_t">Buth J, Harris PL, Hobo R, et al. Neurologic complications associated with endovascular repair of thoracic aortic pathology: Incidence and risk factors. a study from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) registry. J Vasc Surg 2007; 46:1103.</a></li><li><a class="nounderline abstract_t">Freyrie A, Testi G, Gargiulo M, et al. Spinal cord ischemia after endovascular treatment of infrarenal aortic aneurysm. Case report and literature review. J Cardiovasc Surg (Torino) 2011; 52:731.</a></li><li><a class="nounderline abstract_t">Feezor RJ, Martin TD, Hess PJ Jr, et al. Extent of aortic coverage and incidence of spinal cord ischemia after thoracic endovascular aneurysm repair. Ann Thorac Surg 2008; 86:1809.</a></li><li><a class="nounderline abstract_t">Yang GK, Misskey J, Arsenault K, et al. Outcomes of a Spinal Drain and Intraoperative Neurophysiologic Monitoring Protocol in Thoracic Endovascular Aortic Repair. Ann Vasc Surg 2019; 61:124.</a></li><li><a class="nounderline abstract_t">Baril DT, Carroccio A, Ellozy SH, et al. Endovascular thoracic aortic repair and previous or concomitant abdominal aortic repair: is the increased risk of spinal cord ischemia real? Ann Vasc Surg 2006; 20:188.</a></li><li><a class="nounderline abstract_t">Ullery BW, Cheung AT, McGarvey ML, et al. Reversal of delayed-onset paraparesis after revision thoracic endovascular aortic repair for ruptured thoracic aortic aneurysm. Ann Vasc Surg 2011; 25:840.e19.</a></li><li><a class="nounderline abstract_t">Wong CS, Healy D, Canning C, et al. A systematic review of spinal cord injury and cerebrospinal fluid drainage after thoracic aortic endografting. J Vasc Surg 2012; 56:1438.</a></li><li><a class="nounderline abstract_t">Cheung AT, Pochettino A, McGarvey ML, et al. Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg 2005; 80:1280.</a></li><li><a class="nounderline abstract_t">Suarez-Pierre A, Zhou X, Gonzalez JE, et al. Association of preoperative spinal drain placement with spinal cord ischemia among patients undergoing thoracic and thoracoabdominal endovascular aortic repair. J Vasc Surg 2019; 70:393.</a></li><li><a class="nounderline abstract_t">Hanna JM, Andersen ND, Aziz H, et al. Results with selective preoperative lumbar drain placement for thoracic endovascular aortic repair. Ann Thorac Surg 2013; 95:1968.</a></li></ol></div><div id="topicVersionRevision">Topic 93506 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32628988" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28800994" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Perioperative Management of Endovascular Thoracoabdominal Aortic Aneurysm Repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234751" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31141634" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Open versus Endovascular Repair of Abdominal Aortic Aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104785" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085962" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25091544" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12832998" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Does endovascular aortic aneurysm repair justify a reduced cardiology work-up?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30429063" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Preexisting Right Ventricular Dysfunction Is Associated With Higher Postoperative Cardiac Complications and Longer Hospital Stay in High-Risk Patients Undergoing Nonemergent Major Vascular Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14633520" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The importance of intraoperative transesophageal echocardiography in endovascular repair of thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10962409" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Primary endoleakage in endovascular treatment of the thoracic aorta: importance of intraoperative transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15557900" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11165967" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Usefulness of transesophageal echocardiographic monitoring to improve the outcome of stent-graft treatment of thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11957008" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Utility of intraoperative transesophageal echocardiography during endovascular stent-graft repair of acute thoracic aortic dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17456650" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Spontaneous echocardiographic contrast indicating successful endoleak management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29196137" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Transesophageal Echocardiography for Guidance of Endovascular Stent Exclusion of Thoracic Aortic Thrombi: A Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20418689" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25559474" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23966648" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Special article: basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23219414" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1505550" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Improved monitoring of myocardial ischaemia during major vascular surgery using transoesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2221433" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The "natural history" of segmental wall motion abnormalities in patients undergoing noncardiac surgery. S.P.I. Research Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1608139" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17938600" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Electrophysiologic monitoring during surgery to repair the thoraco-abdominal aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22351796" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22353994" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30342821" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Type of Anesthesia for Endovascular Abdominal Aortic Aneurysm Repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32882348" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A meta-analysis of locoregional anesthesia versus general anesthesia in endovascular repair of ruptured abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22727842" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Locoregional anesthesia for endovascular aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31473112" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Local Versus General Anesthesia in Nonemergency Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31344470" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Endovascular Abdominal Aortic Aneurysm Repair: Does Anesthesia Type Matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21646499" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Late outcomes of a single-center experience of 400 consecutive thoracic endovascular aortic repairs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33908261" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : An opioid receptor-independent mechanism underlies motility dysfunction and visceral hyperalgesia in opioid-induced bowel dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931248" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Transversus abdominis plane block: how safe is it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21723069" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Results of endovascular aortic aneurysm repair with general, regional, and local/monitored anesthesia care in the American College of Surgeons National Surgical Quality Improvement Program database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12832999" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Anesthesia for endovascular repair of abdominal and thoracic aortic aneurysms: a review article.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9034920" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Regional anesthesia for endovascular treatment of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29130810" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33218765" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Trials and tribulations of diagnosing and preventing contrast-induced acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32882346" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Spinal cord protection practices used during endovascular repair of complex aortic aneurysms by the U.S. Aortic Research Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9867320" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Renal complications following endovascular repair of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7305662" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Abdominal aortic aneurysm and coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5381329" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Coronary heart disease, stroke, and aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9279306" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Endovascular treatment of infrarenal abdominal aneurysms by the Stentor system: preliminary results of 79 cases. Stentor Retrospective Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12764267" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Blood coagulation and fibrinolytic response after endovascular stent grafting of thoracic aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11743551" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risk of spinal cord ischemia after endograft repair of thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29661408" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cerebrospinal-fluid drain-related complications in patients undergoing open and endovascular repairs of thoracic and thoraco-abdominal aortic pathologies: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29210707" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Images in Anesthesiology: Spinal Subdural Hematoma after Spinal Drain for Endovascular Thoracic Aortic Aneurysm Repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22025398" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Neurological complications of thoracic endovascular aortic repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23339150" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : No increased risk of spinal cord ischemia in delayed AAA repair following thoracic aortic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18154984" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neurologic complications associated with endovascular repair of thoracic aortic pathology: Incidence and risk factors. a study from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18948869" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Spinal cord ischemia after endovascular treatment of infrarenal aortic aneurysm. Case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19021982" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Extent of aortic coverage and incidence of spinal cord ischemia after thoracic endovascular aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31344465" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Outcomes of a Spinal Drain and Intraoperative Neurophysiologic Monitoring Protocol in Thoracic Endovascular Aortic Repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16550478" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Endovascular thoracic aortic repair and previous or concomitant abdominal aortic repair: is the increased risk of spinal cord ischemia real?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21621971" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Reversal of delayed-onset paraparesis after revision thoracic endovascular aortic repair for ruptured thoracic aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22884456" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A systematic review of spinal cord injury and cerebrospinal fluid drainage after thoracic aortic endografting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16181855" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30704799" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Association of preoperative spinal drain placement with spinal cord ischemia among patients undergoing thoracic and thoracoabdominal endovascular aortic repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23635449" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Results with selective preoperative lumbar drain placement for thoracic endovascular aortic repair.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
